Edit |   |
---|---|
Antigenic Specificity | IFNA1, Human (Rontalizumab biosimilar) |
Clone | Rontalizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IFNA1 Recombinant Antibody (Rontalizumab). Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009, it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus. |
Immunogen | n/a |
Other Names | Anti-IFNA1 Recombinant Antibody, Research Grade Rontalizumab, Anti-Human IFNA1 Recombinant Antibody(Rontalizumab), RhuMAB IFNalpha, Antibody Drug Analogues, Monoclonal Antibody, YR1221, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 948570-30-7 |
Catalog # | YR1221 |
Price | please inquire |
Order / More Info | IFNA1, Human (Rontalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |